Identification of responders to cardiac resynchronization therapy by contractile reserve during stress echocardiography

Eur J Heart Fail. 2009 May;11(5):489-96. doi: 10.1093/eurjhf/hfp039. Epub 2009 Mar 26.

Abstract

Aims: The identification of responders to cardiac resynchronization therapy (CRT) remains a challenge. We assessed the role of dyssynchrony (DYS) and contractile reserve (CR) in identifying CRT responders.

Methods and results: Sixty-nine patients (55% with ischaemic aetiology) referred for CRT (ejection fraction < or =35%, New York Heart Association > or =III, and QRS duration > or =120 ms) underwent baseline evaluation of DYS and dobutamine stress-echo [up to 40 microg/kg/min: CR was defined as a wall motion score index (WMSI) variation > or =0.20]. CRT responders were identified by clinical and/or echocardiographic [end-systolic volume (ESV) decrease > or =15%] follow-up criteria. During a median follow-up of 11 months, 46 patients (66%) were classified as clinical responders. Reverse remodelling was found in 34 of the 59 patients (58%) with echocardiographic follow-up. CR was present in 78% of clinical responders (P = 0.001) and in 69% with reverse remodelling (P = 0.005). DYS was equally present in the two groups. Reverse remodelling was correlated with rest-stress changes in ESV (r = 0.439, P = 0.003) and in WMSI (r = 0.450, P = 0.001), but not with DYS. CR (OR = 6.2, 95% CI = 1.4-27.6, P = 0.015) was the best predictor of response to CRT.

Conclusion: Patients with CR show a favourable clinical and reverse LV remodelling response to CRT. This finding shifts the focus from electrical (dyssynchrony) to the myocardial substrate of functional response.

Publication types

  • Comparative Study
  • Multicenter Study

MeSH terms

  • Aged
  • Cardiac Pacing, Artificial / methods*
  • Cardiotonic Agents / administration & dosage
  • Dobutamine / administration & dosage
  • Dose-Response Relationship, Drug
  • Echocardiography, Stress / methods*
  • Female
  • Follow-Up Studies
  • Heart Failure / diagnostic imaging
  • Heart Failure / physiopathology
  • Heart Failure / therapy*
  • Humans
  • Male
  • Myocardial Contraction / drug effects
  • Myocardial Contraction / physiology*
  • Prospective Studies
  • Treatment Outcome
  • Ventricular Function, Left / physiology*
  • Ventricular Remodeling / physiology*

Substances

  • Cardiotonic Agents
  • Dobutamine